SGE-depleted variants are also over-represented in cancer types in which DDX3X has not yet been conclusively demonstrated to be a driver gene, suggesting that DDX3X may play a tumour suppressor role in a wider range of cancers than currently appreciated, and that integrating this variant effect map should increase power in analyses of somatic mutation enrichment. This evidence concerns the gene DDX3X and neoplasm.